Dazukibart

2 trials 2 recruiting Orphan designation

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

10 Countries

Phase III

Phase III: 2

Indications tested

Dermatomyositis 2 Polymyositis 2 Idiopathic inflammatory myopathy 1

Sponsors using this IMP

All trials

2 total

C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN … Recruiting

2022-502739-20-00 Phase III 10 countries Pfizer Inc.
An open-label extension study with dazukibart for participants with idiopathic inflammatory myopathies (including DM or PM) who have complet… Recruiting

2024-514648-10-00 Phase III 6 countries Pfizer Inc.

Showing 1–2 of 2 trials

← All drugs A–Z